Hyderabad firm develops next-gen XBB1.5 Covid vax, awaits trial nod
As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.
Source: rediff.com
Stay updated with breaking news from Vikram Paradkar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As of now, Gennova Biopharmaceuticals has launched a vaccine, Gemcovac-OM, which is based on the Omicron variant.
According to respective company sources, 200 million doses of Corbevax while 50 million doses of Covaxin are ready to dispatch as and when orders are received
The vaccine is found safe & immunogenic in 5-18 age group
In June, the Drugs Controller General of India had approved Corbevax as the first mix-and-match booster dose in the country.
Experts say India’s Covid-19 vaccine policy needs an overhaul to keep up with new data and new variants of coronavirus.